House Democrats will begin considering legislation to lower drug prices at a hearing next week, moving forward on one of their top priorities, according to people familiar with the plan.
The House Energy and Commerce Committee will hold a legislative hearing on March 13 to consider bills to lower drug prices, the sources said.
The measures are slated to be relatively smaller-scale bills that could get some bipartisan support, such as the Creates Act and “pay for delay” legislation, both of which aim to crack down on techniques drug companies use to delay the introduction of cheaper generic drugs.
Lowering drug prices is one of House Democrats’ top priorities; Speaker Nancy Pelosi (D-Calif.) frequently touts drug prices as at the top of the agenda, along with infrastructure and fighting the influence of money in politics.
President Trump has also railed against the high cost of drugs, making the issue one of the rare areas where there could be some chance of bipartisan action.
The smaller-scale measures that Democrats will consider next week are part of a strategy to start with measures that are more likely to be bipartisan and get across the finish line before later moving on to bigger-ticket items like allowing Medicare to negotiate drug prices.
Still, any drug pricing measures always face a tough road, given the contentious nature of the issue and drug industry lobbying.
Committees in both the House and Senate have already held a slew of hearings on the issue of drug prices, but the Energy and Commerce hearing will be the first one this year to consider specific legislation.
In the Senate, Sen. Chuck Grassley (R-Iowa), the chairman of the Finance Committee, also supports the Creates Act and “pay for delay” legislation, raising hopes that those bills could also get through the Senate, although that remains uncertain.